Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Biofrontera Inc (BFRI)
Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Biofrontera Inc. (BFRI) Reports Q3 Loss, Tops Revenue Estimates Zacks - Mon Nov 14, 2022

Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of 28.13% and 0.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BFRI : 0.5900 (+1.67%)
VBLT : 0.1679 (-1.24%)
Entera Bio Ltd. (ENTX) Reports Q3 Loss, Misses Revenue Estimates Zacks - Thu Nov 10, 2022

Entera Bio Ltd. (ENTX) delivered earnings and revenue surprises of 31.25% and 88.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ENTX : 1.3500 (+26.94%)
BFRI : 0.5900 (+1.67%)
Curis (CRIS) Reports Q3 Loss, Misses Revenue Estimates Zacks - Wed Nov 9, 2022

Curis (CRIS) delivered earnings and revenue surprises of 17.65% and 6.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CRIS : 0.5463 (-2.46%)
BFRI : 0.5900 (+1.67%)
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand FinancialNewsMedia - Tue Oct 4, 2022

Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary –  The laser therapy market has been having a very health growth trend in recent years and is expected to continue through...

PIXY : 4.38 (-2.67%)
EW : 81.64 (+1.43%)
BFRI : 0.5900 (+1.67%)
LITE : 52.24 (+2.65%)
CUTR : 23.60 (-4.41%)
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand PR Newswire - Tue Oct 4, 2022

/PRNewswire/ -- The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the coming years....

PIXY : 4.38 (-2.67%)
EW : 81.64 (+1.43%)
BFRI : 0.5900 (+1.67%)
LITE : 52.24 (+2.65%)
CUTR : 23.60 (-4.41%)
Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH Globe Newswire - Mon Aug 1, 2022

Patent Improves Differentiated Profile of Ameluz-PDT by Expected Reduced Pain Intensity while Maintaining Efficacy WOBURN, Mass., Aug. 01, 2022 (GLOBE...

BFRI : 0.5900 (+1.67%)
BFRIW : 0.2000 (+24.92%)
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement Globe Newswire - Wed Jul 27, 2022

WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.2000 (+24.92%)
BFRI : 0.5900 (+1.67%)
Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing Excellence Globe Newswire - Thu Jun 9, 2022

Named Among the 10 Fastest-Growing Life Sciences Companies to Watch in 2022 by CIOCoverage Magazine New Ameluz® Marketing Campaign Receives Gold 2022...

BFRI : 0.5900 (+1.67%)
BFRIW : 0.2000 (+24.92%)
Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conference Globe Newswire - Tue May 31, 2022

WOBURN, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.2000 (+24.92%)
BFRI : 0.5900 (+1.67%)
New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity for Biofrontera’s Ameluz® Globe Newswire - Tue May 24, 2022

WOBURN, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.2000 (+24.92%)
BFRI : 0.5900 (+1.67%)

Barchart Exclusives

The X-Factor that Could Trigger a Gold Boom in the 2nd Half of 2023 Barchart - Wed Mar 29, 5:15PM CDT
Gold prices jumped to $2,000 last week in the wake of the collapse of Silicon Valley Bank. However, this could be just the start of a higher move for the precious metal. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot